Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:18 pm Purchase |
2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Redmile Group LLC | 393,500 9.900% |
29,551 (+8.12%) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Point72 Asset Management, L.P. | 8,647 0.200% |
-176,719 (-95.34%) |
Filing History |
| 2023-02-14 07:31 am Sale |
2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Maverick Capital, Ltd. | 251,641 6.600% |
-62,592 (-19.92%) |
Filing History |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Atara Biotherapeutics, Inc. ATRA |
The Vanguard Group | 288,442 7.600% |
5,421 (+1.92%) |
Filing History |
| 2023-02-09 08:23 am Sale |
2023-02-09 | 13G | Atara Biotherapeutics, Inc. ATRA |
FMR LLC | 5,301 0.139% |
-219,229 (-97.64%) |
Filing History |
| 2023-02-08 3:46 pm Purchase |
2023-02-08 | 13G | Atara Biotherapeutics, Inc. ATRA |
WASATCH ADVISORS LP | 335,641 8.800% |
335,641 (New Position) |
Filing History |
| 2023-02-06 5:36 pm Purchase |
2022-12-30 | 13G | Atara Biotherapeutics, Inc. ATRA |
GOLDMAN SACHS GROUP INC GS |
244,330 6.400% |
244,330 (New Position) |
Filing History |
| 2023-02-03 3:56 pm Purchase |
2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
STATE STREET CORP STT |
305,990 8.060% |
305,990 (New Position) |
Filing History |
| 2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
BlackRock Inc. BLK |
366,086 9.600% |
53,424 (+17.09%) |
Filing History |
| 2023-01-18 1:30 pm Purchase |
2022-12-30 | 13G | Atara Biotherapeutics, Inc. ATRA |
JPMORGAN CHASE & CO JPM |
300,423 7.900% |
3,387 (+1.14%) |
Filing History |
| 2022-03-11 5:05 pm Purchase |
2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Maverick Capital, Ltd. | 314,233 8.400% |
21,251 (+7.25%) |
Filing History |
| 2022-02-14 6:58 pm Purchase |
2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Atara Biotherapeutics Inc. ATRA |
314,233 8.900% |
314,233 (New Position) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Redmile Group LLC | 363,949 9.900% |
49,404 (+15.71%) |
Filing History |
| 2022-02-14 4:28 pm Purchase |
2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Point72 Asset Management, L.P. | 185,366 5.200% |
2,645 (+1.45%) |
Filing History |
| 2022-02-09 5:17 pm Sale |
2022-01-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
BAUPOST GROUP LLC/MA | 324,945 9.190% |
-39,415 (-10.82%) |
Filing History |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
The Vanguard Group | 283,021 8.000% |
57,490 (+25.49%) |
Filing History |
| 2022-02-09 09:09 am Purchase |
2022-02-08 | 13G | Atara Biotherapeutics, Inc. ATRA |
FMR LLC | 224,530 6.348% |
126,220 (+128.39%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
BlackRock Inc. BLK |
312,662 8.800% |
54,485 (+21.10%) |
Filing History |
| 2022-01-07 3:41 pm Purchase |
2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
JPMORGAN CHASE & CO JPM |
297,036 8.300% |
55,896 (+23.18%) |
Filing History |
| 2021-12-21 5:13 pm Purchase |
2021-12-20 | 13G | Atara Biotherapeutics, Inc. ATRA |
Point72 Asset Management, L.P. | 182,721 5.200% |
182,721 (New Position) |
Filing History |